Rasha M. Youssef
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rasha M. Youssef has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Eman I. El-Kimary
Faculty of Pharmacy, Department of Pharmaceutical Analytical Chemistry, University of Alexandria, El-Messalah, Alexandria, Egypt
3 shared publications - Hadir Mohamed Maher
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Alexandria, Egypt
3 shared publications Miranda F. Kamal
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Damanhour University, Beheira, Egypt
2 shared publicationsMohamed A. Korany
Faculty of Pharmacy
2 shared publications- Ahmed N. Allam
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt
1 shared publication - Amira E. El-Dlebshany
Department of Poultry Production, Faculty of Agriculture, Alexandria University, El-Shatby, Alex., Egypt
1 shared publication
Latest Publications
- Open Access
- 6 August 2025
- Published by Springer Nature in BMC Chemistry
- Vol. 19 (1) , 1-9
Environmentally benign carbon nano dots as luminescence probe for quantification of palladium (II) chloride impurity in naproxen
Green shades of “The 2030 Global Green Agenda” have directed the analysts into a peaceful relationship with surrounding environment. Natural resources, clean energy, green solvents are in commitment with Earth’s sustainability. Hazardous inorganic chemical reagents are in gradual replacement by nanoscale reactive species of green origins. In this sense, the present study utilizes nano Carbon Dots, synthesized from garlic peels as natural precursor, with a modified surface activity “multiple active chromophores”. The latter act as potent fluorogenic scavengers for optical nano sensing of Palladium traces in the anti-inflammatory Naproxen drug substance. Palladium traces are found in Naproxen bulk as synthesis-related impurity. Higher ingested levels increase the risk of debilitating diseases in the human body. Stoichiometric reaction between Palladium traces and the dots’ active surfaces was quantified indirectly along the linear spectral diminish of carbon dots luminescence. The proposed methods involve quantitative fluorescence quenching of carbon dots at 432 nm upon excitation at 375 nm and absorption peak at 250 nm upon addition of studied palladium chloride. The obtained results were in good agreement according to the Stern-Volmer equation along the linear range of 0.0088–0.8870 µgmL-1 palladium chloride. The developed procedures were validated as per ICH guidelines.
- 6 August 2025
- Published by Springer Nature in BMC Chemistry
- Vol. 19 (1) , 1-9
Open AccessEnvironmentally benign carbon nano dots as luminescence probe for quantification of palladium (II) chloride impurity in naproxen
Green shades of “The 2030 Global Green Agenda” have directed the analysts into a peaceful relationship with surrounding environment. Natural resources, clean energy, green solvents are in commitment with Earth’s sustainability. Hazardous inorganic chemical reagents are in gradual replacement by nanoscale reactive species of green origins. In this sense, the present study utilizes nano Carbon Dots, synthesized from garlic peels as natural precursor, with a modified surface activity “multiple active chromophores”. The latter act as potent fluorogenic scavengers for optical nano sensing of Palladium traces in the anti-inflammatory Naproxen drug substance. Palladium traces are found in Naproxen bulk as synthesis-related impurity. Higher ingested levels increase the risk of debilitating diseases in the human body. Stoichiometric reaction between Palladium traces and the dots’ active surfaces was quantified indirectly along the linear spectral diminish of carbon dots luminescence. The proposed methods involve quantitative fluorescence quenching of carbon dots at 432 nm upon excitation at 375 nm and absorption peak at 250 nm upon addition of studied palladium chloride. The obtained results were in good agreement according to the Stern-Volmer equation along the linear range of 0.0088–0.8870 µgmL-1 palladium chloride. The developed procedures were validated as per ICH guidelines.
- 20 July 2015
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (18) , 7590-7595
An eco-friendly HPTLC method for assay of eszopiclone in pharmaceutical preparation: investigation of its water-induced degradation kinetics
An eco-friendly, sensitive and selective high-performance thin-layer chromatographic method was developed and validated for analysis of eszopiclone in bulk powder and formulation. The method employed HPTLC aluminium plates precoated with silica gel 60F-254 as the stationary phase. The solvent system consisted of methanol–water (6 : 4, v/v). Densitometric analysis of eszopiclone was carried out at 300 nm. This system was found to give a compact spot for eszopiclone (Rf value of 0.48 ± 0.02). The proposed method was validated for linearity, precision, robustness, LOD, LOQ, specificity and accuracy in accordance with ICH guidelines. Linearity was found to be in the range of 0.2–1.2 μg per band with a significantly high value of correlation coefficient r = 0.9997. Statistical comparison with a reported reference method showed similar results with respect to accuracy and precision. The study of the eszopiclone water-induced degradation kinetics was carried out by the proposed HPTLC method. The activation energy and degradation rate constant at room temperature were calculated after the construction of the Arrhenius plot.
- 20 July 2015
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 7 (18) , 7590-7595
An eco-friendly HPTLC method for assay of eszopiclone in pharmaceutical preparation: investigation of its water-induced degradation kinetics
An eco-friendly, sensitive and selective high-performance thin-layer chromatographic method was developed and validated for analysis of eszopiclone in bulk powder and formulation. The method employed HPTLC aluminium plates precoated with silica gel 60F-254 as the stationary phase. The solvent system consisted of methanol–water (6 : 4, v/v). Densitometric analysis of eszopiclone was carried out at 300 nm. This system was found to give a compact spot for eszopiclone (Rf value of 0.48 ± 0.02). The proposed method was validated for linearity, precision, robustness, LOD, LOQ, specificity and accuracy in accordance with ICH guidelines. Linearity was found to be in the range of 0.2–1.2 μg per band with a significantly high value of correlation coefficient r = 0.9997. Statistical comparison with a reported reference method showed similar results with respect to accuracy and precision. The study of the eszopiclone water-induced degradation kinetics was carried out by the proposed HPTLC method. The activation energy and degradation rate constant at room temperature were calculated after the construction of the Arrhenius plot.
- 1 October 2014
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 27 (5) , 377-384
High-performance thin-layer chromatographic assay of metformin in urine using ion-pair solid-phase extraction: Application for bioavailability and bioequivalence study of new microbeads controlled release formulation
- 1 October 2014
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 27 (5) , 377-384
High-performance thin-layer chromatographic assay of metformin in urine using ion-pair solid-phase extraction: Application for bioavailability and bioequivalence study of new microbeads controlled release formulation
- 25 February 2014
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (10) , 3410-3419
Development of a stability indicating HPLC-DAD method for the simultaneous determination of mometsone furoate and salicylic acid in an ointment matrix
A validated stability-indicating method has been developed for the simultaneous determination of mometsone furoate (MOM) and salicylic acid (SAA) in a combined dosage form. This method is based on the reversed-phase high performance liquid chromatographic (HPLC) separation of the cited drugs. The HPLC separation was performed on a RP Zobrax Eclipse XDB-C8 analytical column (150 × 4.6 mm, 5 μm) with isocratic elution with a mobile phase of methanol and 0.02 M aqueous phosphate buffer (70 : 30) adjusted to pH 2.3 and a flow rate of 1.5 mL min−1. Quantitation was achieved by means of photodiode array detection (DAD) at 260 nm. The calibration graphs for each drug were rectilinear in the range of 0.25–15 and 12.5–750 μg mL−1 for MOM and SAA, respectively using dexamethasone acetate as the internal standard. The proposed HPLC-DAD method was successfully applied in the determination of the investigated drugs in ointment. The method was validated in compliance with ICH guidelines, in terms of linearity, accuracy, precision, robustness, limits of detection and quantitation and specificity.
- 25 February 2014
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (10) , 3410-3419
Development of a stability indicating HPLC-DAD method for the simultaneous determination of mometsone furoate and salicylic acid in an ointment matrix
A validated stability-indicating method has been developed for the simultaneous determination of mometsone furoate (MOM) and salicylic acid (SAA) in a combined dosage form. This method is based on the reversed-phase high performance liquid chromatographic (HPLC) separation of the cited drugs. The HPLC separation was performed on a RP Zobrax Eclipse XDB-C8 analytical column (150 × 4.6 mm, 5 μm) with isocratic elution with a mobile phase of methanol and 0.02 M aqueous phosphate buffer (70 : 30) adjusted to pH 2.3 and a flow rate of 1.5 mL min−1. Quantitation was achieved by means of photodiode array detection (DAD) at 260 nm. The calibration graphs for each drug were rectilinear in the range of 0.25–15 and 12.5–750 μg mL−1 for MOM and SAA, respectively using dexamethasone acetate as the internal standard. The proposed HPLC-DAD method was successfully applied in the determination of the investigated drugs in ointment. The method was validated in compliance with ICH guidelines, in terms of linearity, accuracy, precision, robustness, limits of detection and quantitation and specificity.
- 1 October 2013
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 26 (5) , 427-434
Validated high-performance thin-layer chromatographic method for the evaluation of oseltamivir pharmaceutical formulations counterfeited with ascorbic acid compared with a colorimetric method
- 1 October 2013
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 26 (5) , 427-434
Validated high-performance thin-layer chromatographic method for the evaluation of oseltamivir pharmaceutical formulations counterfeited with ascorbic acid compared with a colorimetric method
- 28 May 2013
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 36 (14) , 2044-2058
MONITORING OF METRONIDAZOLE AND ITS METABOLITE RESIDUES IN EGGS OF TWO STRAINS OF HENS USING HPLC-DAD
HPLC-DAD method based on solid-phase extraction was developed for residual determination of metronidazole (MET) and its metabolite hydroxymetronidazole (MET-OH) in two strains of hen eggs (Alexandria egg line, AE and Fayoumi egg line, PP). The LC separation was performed on a RP C-18 analytical column (150 mm × 4.6 mm, 5 µm) with an isocratic elution system of 0.0 5 M phosphate buffer of pH 2.5–acetonitrile (95:5) as the mobile phase. The procedure was evaluated and fully validated. The calibration graphs for MET and MET-OH were rectilinear in the range of 0.3–16.0 µg g−1 for MET and 0.2–20.0 µg g−1 for MET-OH. No residues could be detected before the 3rd day or after 11th day after the drug administration. The drug and metabolite concentration levels in eggs for the two strains of hens were different owing to their change in genetic potential. PP has less ability to keep MET and MET-OH residues than AE.
- 28 May 2013
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 36 (14) , 2044-2058
MONITORING OF METRONIDAZOLE AND ITS METABOLITE RESIDUES IN EGGS OF TWO STRAINS OF HENS USING HPLC-DAD
HPLC-DAD method based on solid-phase extraction was developed for residual determination of metronidazole (MET) and its metabolite hydroxymetronidazole (MET-OH) in two strains of hen eggs (Alexandria egg line, AE and Fayoumi egg line, PP). The LC separation was performed on a RP C-18 analytical column (150 mm × 4.6 mm, 5 µm) with an isocratic elution system of 0.0 5 M phosphate buffer of pH 2.5–acetonitrile (95:5) as the mobile phase. The procedure was evaluated and fully validated. The calibration graphs for MET and MET-OH were rectilinear in the range of 0.3–16.0 µg g−1 for MET and 0.2–20.0 µg g−1 for MET-OH. No residues could be detected before the 3rd day or after 11th day after the drug administration. The drug and metabolite concentration levels in eggs for the two strains of hens were different owing to their change in genetic potential. PP has less ability to keep MET and MET-OH residues than AE.
- 1 March 2013
- Published by Oxford University Press (OUP)
- Vol. 96 (2) , 313-323
Validated Stability-Indicating Methods for the Simultaneous Determination of Amiloride Hydrochloride, Atenolol, and Chlorthalidone Using HPTLC and HPLC with Photodiode Array Detector
Two stability-indicating chromatographic methods are described for simultaneous determination of amiloride hydrochloride (AMI), atenolol (ATE), and chlorthalidone (CHL) in combined dosage forms. The first method was based on HPTLC separation of the three drugs followed by densitometric measurements of their bands at 274 nm. The separation was carried out on Merck HPTLC silica gel 60F254 aluminum sheets using chloroform–methanol–ammonia 27%, w/w (9 + 2 + 0.3, v/v/v) mobile phase. Analysis data was used for the linear regression graph in the range of 0.1–0.5, 0.8–5.0, and 0.3–1.5 μg/band for AMI, ATE, and CHL, respectively. The second method was based on an RP-HPLC separation of the cited drugs performed on an RP stainless steel C18 analytical column (250 × 4.6 mm id) with a gradient elution system of methanol and 0.05 M aqueous phosphate buffer adjusted to pH 4 as the mobile phase, at the flow rate of 1.0 mL/min. Quantitation was achieved with photodiode array detection at 275 nm for AMI and 225 nm for ATE and CHL. The calibration graphs for each drug were rectilinear in the range of 2–50, 25–150, and 2–100 μg/mL for AMI, ATE, and CHL, respectively. The proposed chromatographic methods were successfully applied for determination of the investigated drugs in pharmaceutical preparations. Both methods were validated in compliance with International Conference on Harmonization guidelines in terms of linearity, accuracy, precision, robustness, LOD, and LOQ.
- 1 March 2013
- Published by Oxford University Press (OUP)
- Vol. 96 (2) , 313-323
Validated Stability-Indicating Methods for the Simultaneous Determination of Amiloride Hydrochloride, Atenolol, and Chlorthalidone Using HPTLC and HPLC with Photodiode Array Detector
Two stability-indicating chromatographic methods are described for simultaneous determination of amiloride hydrochloride (AMI), atenolol (ATE), and chlorthalidone (CHL) in combined dosage forms. The first method was based on HPTLC separation of the three drugs followed by densitometric measurements of their bands at 274 nm. The separation was carried out on Merck HPTLC silica gel 60F254 aluminum sheets using chloroform–methanol–ammonia 27%, w/w (9 + 2 + 0.3, v/v/v) mobile phase. Analysis data was used for the linear regression graph in the range of 0.1–0.5, 0.8–5.0, and 0.3–1.5 μg/band for AMI, ATE, and CHL, respectively. The second method was based on an RP-HPLC separation of the cited drugs performed on an RP stainless steel C18 analytical column (250 × 4.6 mm id) with a gradient elution system of methanol and 0.05 M aqueous phosphate buffer adjusted to pH 4 as the mobile phase, at the flow rate of 1.0 mL/min. Quantitation was achieved with photodiode array detection at 275 nm for AMI and 225 nm for ATE and CHL. The calibration graphs for each drug were rectilinear in the range of 2–50, 25–150, and 2–100 μg/mL for AMI, ATE, and CHL, respectively. The proposed chromatographic methods were successfully applied for determination of the investigated drugs in pharmaceutical preparations. Both methods were validated in compliance with International Conference on Harmonization guidelines in terms of linearity, accuracy, precision, robustness, LOD, and LOQ.
- 1 October 2012
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 25 (5) , 456-462
Validated HPTLC method for simultaneous determination of loratadine and desloratadine in presence of Co-formulated drug
- 1 October 2012
- Published by Akademiai Kiado Zrt. in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 25 (5) , 456-462
Validated HPTLC method for simultaneous determination of loratadine and desloratadine in presence of Co-formulated drug
- 29 December 2010
- Published by Wiley in Drug Testing and Analysis
- Vol. 3 (4) , 214-220
Kinetic spectrophotometric methods for the determination of artificial sweetener (sucralose) in tablets
Two simple and sensitive kinetic spectrophotometric methods for the determination of sucralose are described. The first method is based upon a kinetic investigation of the oxidation reaction of the drug with alkaline potassium permanganate at room temperature for a fixed time of 30 min. The absorbance of the green coloured manganate ions produced was measured at 610 nm. The second method is based on the reaction of sucralose with cerium (IV) ammonium sulfate in the presence of perchloric acid with the subsequent measurement of the excess unreacted cerium (IV) ammonium sulfate at 320 nm at a fixed time of 30 min in a thermostated water bath at 60 ± 1 °C. This principle is adopted to develop a kinetic method for sucralose determination. The absorbance concentration plots in both methods were rectilinear over the range 4-16 and 10-30 µg ml(-1) , for the first and second methods, respectively. The different experimental parameters affecting the development and stability of the colours were carefully studied and optimized. The determination of sucralose by rate constant method, fixed concentration method, and fixed-time method was also feasible with calibration equations obtained but the latter method was found to be more applicable. The two methods have been applied successfully to commercial tablets.
- 29 December 2010
- Published by Wiley in Drug Testing and Analysis
- Vol. 3 (4) , 214-220
Kinetic spectrophotometric methods for the determination of artificial sweetener (sucralose) in tablets
Two simple and sensitive kinetic spectrophotometric methods for the determination of sucralose are described. The first method is based upon a kinetic investigation of the oxidation reaction of the drug with alkaline potassium permanganate at room temperature for a fixed time of 30 min. The absorbance of the green coloured manganate ions produced was measured at 610 nm. The second method is based on the reaction of sucralose with cerium (IV) ammonium sulfate in the presence of perchloric acid with the subsequent measurement of the excess unreacted cerium (IV) ammonium sulfate at 320 nm at a fixed time of 30 min in a thermostated water bath at 60 ± 1 °C. This principle is adopted to develop a kinetic method for sucralose determination. The absorbance concentration plots in both methods were rectilinear over the range 4-16 and 10-30 µg ml(-1) , for the first and second methods, respectively. The different experimental parameters affecting the development and stability of the colours were carefully studied and optimized. The determination of sucralose by rate constant method, fixed concentration method, and fixed-time method was also feasible with calibration equations obtained but the latter method was found to be more applicable. The two methods have been applied successfully to commercial tablets.
- 1 August 2010
- Published by Wiley in Drug Testing and Analysis
- Vol. 2 (8) , 392-396
Electrochemical study of spiramycin and its determination in pharmaceutical preparation
Spiramycin (SPY) is a medium‐spectrum antibiotic with high effectiveness against Gram‐positive bacteria. The voltammetric behaviour of spiramycin was studied using differential pulse polarography (DPP) and square wave polarography (SWP). The drug in Britton‐Robinson buffer (pH 11.5) is reduced at − 1.45 V, giving rise to a well‐defined cathodic peak using hanging mercury drop electrode (HMDE) versus Ag/AgCl electrode. This peak is attributed to the reduction of the aldehyde group. The results proved that the reduction of SPY is an irreversible diffusion‐controlled process. The diffusion current‐concentration relationship was shown to be rectilinear over the range of 20–80 and 0.8–80 µg ml−1 using DPP and SWP modes, respectively, with detection limit of 8.5 µg ml−1 (1.01 × 10−5 M) and 0.46 µg ml−1 (5.46 × 10−7 M) for DPP and SWP modes, respectively. A mechanism is postulated for the reduction of SPY. The proposed techniques were successfully applied to the determination of the studied compound either in pure form or in its formulation. Copyright © 2010 John Wiley & Sons, Ltd.
- 1 August 2010
- Published by Wiley in Drug Testing and Analysis
- Vol. 2 (8) , 392-396
Electrochemical study of spiramycin and its determination in pharmaceutical preparation
Spiramycin (SPY) is a medium‐spectrum antibiotic with high effectiveness against Gram‐positive bacteria. The voltammetric behaviour of spiramycin was studied using differential pulse polarography (DPP) and square wave polarography (SWP). The drug in Britton‐Robinson buffer (pH 11.5) is reduced at − 1.45 V, giving rise to a well‐defined cathodic peak using hanging mercury drop electrode (HMDE) versus Ag/AgCl electrode. This peak is attributed to the reduction of the aldehyde group. The results proved that the reduction of SPY is an irreversible diffusion‐controlled process. The diffusion current‐concentration relationship was shown to be rectilinear over the range of 20–80 and 0.8–80 µg ml−1 using DPP and SWP modes, respectively, with detection limit of 8.5 µg ml−1 (1.01 × 10−5 M) and 0.46 µg ml−1 (5.46 × 10−7 M) for DPP and SWP modes, respectively. A mechanism is postulated for the reduction of SPY. The proposed techniques were successfully applied to the determination of the studied compound either in pure form or in its formulation. Copyright © 2010 John Wiley & Sons, Ltd.